Carotid Artery Diseases
Pathological conditions involving the CAROTID ARTERIES, including the common, internal, and external carotid arteries. ATHEROSCLEROSIS and TRAUMA are relatively frequent causes of carotid artery pathology.
Subtype terms (6)
More specific conditions that are subtypes of Carotid Artery Diseases in the MeSH hierarchy.
- Carotid Artery Injuries
3 drugs approved
- Carotid Artery Thrombosis
- Carotid-Cavernous Sinus Fistula
- Carotid Stenosis
59 drugs (42 approved, 17 experimental)
- Carotid Webs
- Moyamoya Disease
7 drugs (5 approved, 2 experimental)
Drugs by status
Approved for this indication (1)
Phase 4 trials (12)
Phase 3 trials (10)
Phase 2 trials (12)
Phase 1 trials (5)
Organizations
Organization Involved with Phase 4 Indications (23)
- Abbott
- Daiichi Sankyo
- AstraZeneca
- Merck
- Pfizer
- Jeil Pharmaceutical Co., Ltd.
- Kos Pharmaceuticals
- Upsher-Smith Laboratories
- The Dana Foundation
- National Heart, Lung, and Blood Institute (NHLBI)
- University of Pennsylvania
- University of Washington
- Seoul National University
- University of Glasgow
- University of Southern Denmark
- Peking University
- University of Campinas
- Carl T. Hayden Medical Research Foundation
- Catholic University of Korea
- Department of Veteran Affairs
- Beijing Clinstech-med consulting Co., Ltd
- Government of Scotland
- Beijing Sino-Japan Friendship Hospital
Organization Involved with Phase 3 Indications (2)
Organization Involved with Phase 2 Indications (11)
- National Center for Complementary and Integrative Health (NCCIH)
- Emory University
- Harbin Medical University
- Institute for Atherosclerosis Research, Russia
- Stanford University
- University of Lausanne
- University of Rochester
- Tsinghua University
- Office of Dietary Supplements (ODS)
- General Electric
- Swiss Heart Foundation
Organization Involved with Phase 1 Indications (2)
Organization Involved with Other Experimental Indications (9)